Assessment and Treatment in Autism Spectrum Disorders: a Focus on Genetics and Psychiatry

Overview

Journal Autism Res Treat

Date 2012 Aug 31

PMID 22934170

Citations 8

Authors

Merlin G Butler

Erin L Youngs

Jennifer L Roberts

Jessica A Hellings

Affiliations

Soon will be listed here.

Abstract

Autism spectrum disorders (ASDs) are neurobehavioral disorders characterized by abnormalities in three behavioral domains including social interaction, impaired communication, and repetitive stereotypic behaviors. ASD affects approximately 1% of children and is on the rise with significant genetic mechanisms underlying these disorders. We review the current understanding of the role of genetic and metabolic factors contributing to ASD with the use of new genetic technology. Fifty percent is diagnosed with chromosomal abnormalities, small DNA deletions/duplications, single-gene conditions, or metabolic disturbances. Genetic evaluation is discussed along with psychiatric treatment and approaches for selection of medication to treat associated challenging behaviors or comorbidities seen in ASD. We emphasize the importance of prioritizing treatment based on target symptom clusters and in what order for individuals with ASD, as the treatment may vary from patient to patient.

Citing Articles

Understanding Mental Health Issues in Different Subdomains of Social Networking Services: Computational Analysis of Text-Based Reddit Posts.

Kim S, Cha J, Kim D, Park E J Med Internet Res. 2023; 25:e49074.

PMID: 38032730 PMC: 10722371. DOI: 10.2196/49074.

The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations.

Genovese A, Butler M Genes (Basel). 2023; 14(3).

PMID: 36980949 PMC: 10048473. DOI: 10.3390/genes14030677.

Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD).

Genovese A, Butler M Int J Mol Sci. 2020; 21(13).

PMID: 32630718 PMC: 7369758. DOI: 10.3390/ijms21134726.

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder.

Alolaby R, Jiraanont P, Durbin-Johnson B, Jasoliya M, Tang H, Hagerman R Front Genet. 2020; 11:308.

PMID: 32346385 PMC: 7174723. DOI: 10.3389/fgene.2020.00308.

A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

DeMayo M, Song Y, Hickie I, Guastella A Paediatr Drugs. 2017; 19(5):391-410.

PMID: 28721467 DOI: 10.1007/s40272-017-0248-y.

References

Schaefer G, Mendelsohn N . Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med. 2008; 10(4):301-5. PMC: 3111012. DOI: 10.1097/GIM.0b013e31816b5cc9. View

Wallace D . Mitochondrial diseases in man and mouse. Science. 1999; 283(5407):1482-8. DOI: 10.1126/science.283.5407.1482. View

Polsek D, Jagatic T, Cepanec M, Hof P, Simic G . RECENT DEVELOPMENTS IN NEUROPATHOLOGY OF AUTISM SPECTRUM DISORDERS. Transl Neurosci. 2011; 2(3):256-264. PMC: 3237008. DOI: 10.2478/s13380-011-0024-3. View

Butler M, Dasouki M, Zhou X, Talebizadeh Z, Brown M, Takahashi T . Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005; 42(4):318-21. PMC: 1736032. DOI: 10.1136/jmg.2004.024646. View

Hollander E, Wasserman S, Swanson E, Chaplin W, Schapiro M, Zagursky K . A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol. 2006; 16(5):541-8. DOI: 10.1089/cap.2006.16.541. View

Scahill L, Aman M, McDougle C, McCracken J, Tierney E, Dziura J . A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006; 16(5):589-98. DOI: 10.1089/cap.2006.16.589. View

Hellings J, Boehm D, Yeh H, Butler M, Schroeder S . Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. J Ment Health Res Intellect Disabil. 2017; 4(1):40-52. PMC: 5287698. DOI: 10.1080/19315864.2010.542274. View

Lecavalier L . Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord. 2006; 36(8):1101-14. DOI: 10.1007/s10803-006-0147-5. View

Weissman J, Kelley R, Bauman M, Cohen B, Murray K, L Mitchell R . Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One. 2008; 3(11):e3815. PMC: 2584230. DOI: 10.1371/journal.pone.0003815. View

10.

Schaefer G, Lutz R . Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med. 2006; 8(9):549-56. DOI: 10.1097/01.gim.0000237789.98842.f1. View

11.

Holt R, Monaco A . Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Mol Med. 2011; 3(8):438-50. PMC: 3377085. DOI: 10.1002/emmm.201100157. View

12.

Goff D, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld D . A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999; 56(1):21-7. DOI: 10.1001/archpsyc.56.1.21. View

13.

Glessner J, Wang K, Cai G, Korvatska O, Kim C, Wood S . Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009; 459(7246):569-73. PMC: 2925224. DOI: 10.1038/nature07953. View

14.

Lord C, Risi S, Lambrecht L, Cook Jr E, Leventhal B, DiLavore P . The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000; 30(3):205-23. View

15.

Lockhart P, Guthrie B . Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract. 2011; 61(590):e565-72. PMC: 3162179. DOI: 10.3399/bjgp11X593848. View

16.

Feldman H, Kolmen B, Gonzaga A . Naltrexone and communication skills in young children with autism. J Am Acad Child Adolesc Psychiatry. 1999; 38(5):587-93. DOI: 10.1097/00004583-199905000-00021. View

17.

Hellings J . Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. J Clin Psychopharmacol. 2006; 26(3):344-6. DOI: 10.1097/01.jcp.0000219924.04058.99. View

18.

Lainhart J, Piven J, Wzorek M, Landa R, Santangelo S, Coon H . Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry. 1997; 36(2):282-90. DOI: 10.1097/00004583-199702000-00019. View

19.

Piven J . The biological basis of autism. Curr Opin Neurobiol. 1998; 7(5):708-12. DOI: 10.1016/s0959-4388(97)80093-1. View

20.

Jaselskis C, Cook Jr E, Fletcher K, Leventhal B . Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol. 1992; 12(5):322-7. View